All sponsors

Shanghai Vitalgen BioPharma Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING0
READOUTS ≤12 MONTHS3
Open Shanghai Vitalgen BioPharma Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
VGN-R09b injection
NCT06432140
P2/3Active, not recruitingAromatic L-amino Acid Decarboxylase Deficiency132026-07-23 (+2 mo)
VGN-R09b
NCT06480461
P1/2Active, not recruitingParkinson's Disease392026-09-10 (-10 mo)
VGR-R01
NCT06699108
P3Active, not recruitingBietti Crystalline Dystrophy; Inherited Retinal Diseases452026-12-01
VGR-R01
NCT07586306
P1/2Not yet recruitingBietti Crystalline Dystrophy152027-07-31
VGN-R08b 4.2×10^13 vg
NCT07414290
P1/2Not yet recruitingParkinson Disease (PD)172027-09-01
VGN-R08b
NCT07603050
P1/2Not yet recruitingGaucher Disease Type 3122028-05-29